References
- Gustavsson B, Carlsson G, Machover D, Petrelli N, Roth A, Schmoll H-J, Tveit K-M, Gibson F. A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer. 2015;14(1):1–10. doi:https://doi.org/10.1016/j.clcc.2014.11.002
- Butler MS, Robertson AAB, Cooper MA. Natural product and natural product derived drugs in clinical trials. Nat Prod Rep. 2014;31(11):1612–61. doi:https://doi.org/10.1039/c4np00064a
- Huang X, Yang Z, Xie Q, Zhang Z, Zhang H, Ma J. Natural products for treating colorectal cancer: a mechanistic review. Biomed Pharmacother. 2019;117:109142. doi:https://doi.org/10.1016/j.biopha.2019.109142
- Rejhová A, Opattová A, Čumová A, Slíva D, Vodička P. Natural compounds and combination therapy in colorectal cancer treatment. Eur J Med Chem. 2018;144:582–94. doi:https://doi.org/10.1016/j.ejmech.2017.12.039
- Cort A, Ozben T. Natural product modulators to overcome multidrug resistance in cancer. Nutr Cancer. 2015;67(3):411–23. doi:https://doi.org/10.1080/01635581.2015.1002624
- Popović V, Živković J, Davidović S, Stevanović M, Stojković D. Mycotherapy of cancer: an update on cytotoxic and antitumor activities of mushrooms, bioactive principles and molecular mechanisms of their action. Curr Top Med Chem. 2013;13(21):2791–806. doi:https://doi.org/10.2174/15680266113136660198
- Zhang S, Nie S, Huang D, Li W, Xie M. Immunomodulatory effect of Ganoderma atrum polysaccharide on CT26 tumor-bearing mice. Food Chem. 2013;136(3-4):1213–9. doi:https://doi.org/10.1016/j.foodchem.2012.08.090
- Wang C-L, Lu C-Y, Hsueh Y-C, Liu W-H, Chen C-J. Activation of antitumor immune responses by Ganoderma formosanum polysaccharides in tumor-bearing mice. Appl Microbiol Biotechnol. 2014;98(22):9389–98. doi:https://doi.org/10.1007/s00253-014-6027-6
- Na K, Li K, Sang T, Wu K, Wang Y, Wang X. Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo. Int J Oncol. 2017;50(5):1541–54. doi:https://doi.org/10.3892/ijo.2017.3939
- Richter C, Wittstein K, Kirk PM, Stadler M. An assessment of the taxonomy and chemotaxonomy of Ganoderma. Fungal Divers. 2015;71(1):1–15. doi:https://doi.org/10.1007/s13225-014-0313-6
- Tan W-C, Kuppusamy UR, Phan C-W, Tan Y-S, Raman J, Anuar AM, Sabaratnam V. Ganoderma neo-japonicum Imazeki revisited: domestication study and antioxidant properties of its basidiocarps and mycelia. Sci Rep. 2015;5:12515. doi:https://doi.org/10.1038/srep12515
- Lin J-M, Lin C-C, Chen M-F, Ujiie T, Takada A. Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum. J Ethnopharmacol. 1995;47(1):33–41. doi:https://doi.org/10.1016/0378-8741(95)01251-8
- Seow SL-S, Naidu M, David P, Wong K-H, Sabaratnam V. Potentiation of neuritogenic activity of medicinal mushrooms in rat pheochromocytoma cells. BMC Complement Altern Med. 2013;13(1):157. doi:https://doi.org/10.1186/1472-6882-13-157
- Ubaidillah NHN, Abdullah N, Sabaratnam V. Isolation of the intracellular and extracellular polysaccharides of Ganoderma neojaponicum (Imazeki) and characterization of their immunomodulatory properties. Electron J Biotechnol. 2015;18(3):188–95. doi:https://doi.org/10.1016/j.ejbt.2015.03.006
- Tan WC, Kuppusamy UR, Phan CW, Sabaratnam V. Cell proliferation and DNA repair ability of Ganoderma neo-japonicum (Agaricomycetes): an indigenous medicinal mushroom from Malaysia. Int J Med Mushrooms. 2018;20(2):155–63. doi:https://doi.org/10.1615/IntJMedMushrooms.2018025445
- Subramaniam S, Sabaratnam V, Heng CK, Kuppusamy UR. The medicinal mushroom Ganoderma neo-japonicum (Agaricomycetes) from Malaysia: nutritional composition and potentiation of insulin-like activity in 3T3-L1 cells. Int J Med Mushrooms. 2020;22(1):65–78. doi:https://doi.org/10.1615/IntJMedMushrooms.2020033250
- Gurunathan S, Raman J, Abd Malek SN, John PA, Vikineswary S. Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. Int J Nanomedicine. 2013;8:4399–413. doi:https://doi.org/10.2147/IJN.S51881
- Lau M-F, Chua K-H, Sabaratnam V, Kuppusamy UR. In vitro and in silico anticancer evaluation of a medicinal mushroom. Ganoderma neo-japonicum Imazeki, against human colonic carcinoma cells. Biotechnol Appl Biochem. 2020. https://doi.org/10.1002/bab.2013.
- Gerards MC, van der Velden DL, Baars JW, Brandjes DPM, Hoekstra JBL, Vriesendorp TM, Gerdes VEA . Impact of hyperglycemia on the efficacy of chemotherapy-A systematic review of preclinical studies. Crit Rev Oncol Hematol. 2017;113:235–41. doi:https://doi.org/10.1016/j.critrevonc.2017.03.007
- Lau M-F, Chua K-H, Sabaratnam V, Kuppusamy UR. Rosiglitazone enhances the apoptotic effect of 5-fluorouracil in colorectal cancer cells with high-glucose-induced glutathione. Sci Prog. 2019;10:0036850419886448.
- Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. doi:https://doi.org/10.1038/nmeth.2019
- Patel S, Goyal A. Recent developments in mushrooms as anti-cancer therapeutics: a review. 3 Biotech. 2012;2(1):1–15. doi:https://doi.org/10.1007/s13205-011-0036-2
- Lau M-F, Vellasamy S, Chua K-H, Sabaratnam V, Kuppusamy UR. Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells. . 2018;17:186–99. doi:https://doi.org/10.17179/excli2018-1011
- Ma YS, Yang IP, Tsai HL, Huang CW, Juo SHH, Wang JY. High glucose modulates antiproliferative effect and cytotoxicity of 5-fluorouracil in human colon cancer cells. DNA Cell Biol. 2014;33(2):64–72. doi:https://doi.org/10.1089/dna.2013.2161
- Mattson MP. Hormesis defined. Ageing Res Rev. 2008;7(1):1–7. doi:https://doi.org/10.1016/j.arr.2007.08.007
- Veljović S, Veljović M, Nikićević N, Despotović S, Radulović S, Nikšić M, Filipović L. Chemical composition, antiproliferative and antioxidant activity of differently processed Ganoderma lucidum ethanol extracts. J Food Sci Technol. 2017;54(5):1312–20. doi:https://doi.org/10.1007/s13197-017-2559-y
- Li K, Na K, Sang T, Wu K, Wang Y, Wang X. The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo. Oncol Rep. 2017;38(5):2803–13. doi:https://doi.org/10.3892/or.2017.6010
- de Silva DD, Rapior S, Fons F, Bahkali AH, Hyde KD. Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action. Fungal Divers. 2012;55(1):1–35. doi:https://doi.org/10.1007/s13225-012-0151-3
- Ferreira ICFR, Vaz JA, Vasconcelos MH, Martins A. Compounds from wild mushrooms with antitumor potential. Anticancer Agents Med Chem. 2010;10(5):424–36. doi:https://doi.org/10.2174/1871520611009050424
- Opattova A, Horak J, Vodenkova S, Kostovcikova K, Cumova A, Macinga P, Galanova N, Rejhova A, Vodickova L, Kozics K, et al. Ganoderma lucidum induces oxidative DNA damage and enhances the effect of 5-fluorouracil in colorectal cancer in vitro and in vivo. Mutat Res. 2019;845:403065. doi:https://doi.org/10.1016/j.mrgentox.2019.06.001
- Finimundy TC, Abreu RMV, Bonetto N, Scariot FJ, Dillon AJP, Echeverrigaray S, Barros L, Ferreira ICFR, Henriques JAP, Roesch-Ely M. Apoptosis induction by Pleurotus sajor-caju (Fr.) Singer extracts on colorectal cancer cell lines. Food Chem Toxicol. 2018;112:383–92. doi:https://doi.org/10.1016/j.fct.2018.01.015
- Wang Y, Cheng X, Wang P, Wang L, Fan J, Wang X, Liu Q. Investigating migration inhibition and apoptotic effects of Fomitopsis pinicola chloroform extract on human colorectal cancer SW-480 cells. PloS One. 2014;9(7):e101303. doi:https://doi.org/10.1371/journal.pone.0101303
- Marrocco I, Altieri F, Peluso I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017;2017:6501046. doi:https://doi.org/10.1155/2017/6501046
- Avinash SS, Anitha M, VinodchandranRao GM, Sudha K, Shetty BV. Advanced oxidation protein products and total antioxidant activity in colorectal carcinoma. Indian J Physiol Pharmacol. 2009;53(4):370–4.
- Chang D, Wang F, Zhao Y-S, Pan H-Z. Evaluation of oxidative stress in colorectal cancer patients. Biomed Environ Sci. 2008;21(4):286–9. doi:https://doi.org/10.1016/S0895-3988(08)60043-4
- Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta. 2004;1689(2):91–102. doi:https://doi.org/10.1016/j.bbadis.2004.02.008
- Mehrabi S, Wallace L, Cohen S, Yao X, Aikhionbare FO. Differential measurements of oxidatively modified proteins in colorectal adenopolyps. Int J Clin Med. 2015;6(4):288–99.
- Ribeiro ML, Priolli DG, Miranda DDC, Arcari DP, Pedrazzoli JJ, Martinez CAR. Analysis of oxidative DNA damage in patients with colorectal cancer. Clin Colorectal Cancer. 2008;7(4):267–72. doi:https://doi.org/10.3816/CCC.2008.n.034
- Skrzydlewska E, Sulkowski S, Koda M, Zalewski B, Kanczuga-Koda L, Sulkowska M. Lipid peroxidation and antioxidant status in colorectal cancer. WJG. 2005;11(3):403–6. doi:https://doi.org/10.3748/wjg.v11.i3.403
- Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12(1):376–90. doi:https://doi.org/10.1016/j.arr.2012.10.004
- Landriscina M, Maddalena F, Laudiero G, Esposito F. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal. 2009;11(11):2701–16. doi:https://doi.org/10.1089/ars.2009.2692
- Zhao M, Liu Q, Gong Y, Xu X, Zhang C, Liu X, Zhang C, Guo H, Zhang X, Gong Y, et al. GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment. Cell Cycle. 2016;15(8):1125–33. doi:https://doi.org/10.1080/15384101.2016.1158374
- Kim AD, Zhang R, Han X, Kang KA, Piao MJ, Maeng YH, Chang WY, Hyun JW. Involvement of glutathione and glutathione metabolizing enzymes in human colorectal cancer cell lines and tissues. Mol Med Rep. 2015;12(3):4314–9. doi:https://doi.org/10.3892/mmr.2015.3902
- Riganti C, Gazzano E, Polimeni M, Aldieri E, Ghigo D. The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. Free Radic Biol Med. 2012;53(3):421–36. doi:https://doi.org/10.1016/j.freeradbiomed.2012.05.006
- Takahashi S, Izawa Y, Suzuki N. Astroglial pentose phosphate pathway rates in response to high-glucose environments. ASN Neuro. 2012;4(2):e00078. doi:https://doi.org/10.1042/AN20120002
- Tsay JG, Chung KT, Yeh CH, Chen WL, Chen CH, Lin MHC, Lu FJ, Chiou JF, Chen CH. Calvatia lilacina protein-extract induces apoptosis through glutathione depletion in human colorectal carcinoma cells. J Agric Food Chem. 2009;57(4):1579–88. doi:https://doi.org/10.1021/jf8030265
- Wu JY, Chen CH, Chang WH, Chung KT, Liu YW, Lu FJ, Chen CH. 2011; Anti-cancer effects of protein extracts from Calvatia lilacina, Pleurotus ostreatus and Volvariella volvacea. Evid Based Complementary Altern Med. 20112011:1–10. doi:https://doi.org/10.1093/ecam/neq057
- Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer. 2000;89(7):1440–7. doi:https://doi.org/10.1002/1097-0142(20001001)89:7<1440::AID-CNCR5>3.0.CO;2-0
- Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ. Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells. Biochem Pharmacol. 1999;58(4):655–64. doi:https://doi.org/10.1016/s0006-2952(99)00130-6
- Arzumanian V, Stankevicius E, Laukeviciene A, Kevelaitis E. [Mechanisms of nitric oxide synthesis and action in cells]. Medicina (Kaunas). 2003;39(6):535–41.
- Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW, Moncada S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer. 1994;70(5):847–9. doi:https://doi.org/10.1038/bjc.1994.409
- Siegert A, Rosenberg C, Schmitt WD, Denkert C, Hauptmann S. Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion. Br J Cancer. 2002;86(8):1310–5. doi:https://doi.org/10.1038/sj.bjc.6600224
- Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR, Harris CC. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med. 1998;4(12):1371–6. doi:https://doi.org/10.1038/3957
- Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 1995;92(10):4392–6. doi:https://doi.org/10.1073/pnas.92.10.4392
- Han MD, Lee ES, Kim YK, Lee JW, Jeong H, Yoon KH. [Production of nitric oxide in Raw 264.7 macrophages treated with Ganoderan, the β − Glucan of Ganoderma lucidum]. Korean J. Mycol. 1998;26(2):246–55. Korean.
- Ghazanfari T, Yaraee R, Farahnejad Z, Hakimzadeh H, Danialy F. In vitro effect of Pleurotus florida on macrophage cell viability and nitric oxide production. Food Agric Immunol. 2009;20(2):105–10. doi:https://doi.org/10.1080/09540100902838198
- Epstein T, Gatenby RA, Brown JS. The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand. PLoS One. 2017;12(9):e0185085. doi:https://doi.org/10.1371/journal.pone.0185085
- Jóźwiak P, Krześlak A, Bryś M, Lipińska A . Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells. Oncol Rep. 2015;33(2):913–20. doi:https://doi.org/10.3892/or.2014.3673
- Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab. 2000;26(3):163–76.
- Barnum KJ, O’Connell MJ. Cell cycle regulation by checkpoints. Methods Mol Biol. 2014;1170:29–40. doi:https://doi.org/10.1007/978-1-4939-0888-2_2
- OuYang F, Wang G, Guo W, Zhang Y, Xiang W, Zhao M. AKT signalling and mitochondrial pathways are involved in mushroom polysaccharide-induced apoptosis and G1 or S phase arrest in human hepatoma cells. Food Chem. 2013;138(4):2130–9. doi:https://doi.org/10.1016/j.foodchem.2012.10.047
- Yu Y-H, Kuo H-P, Hsieh H-H, Li J-W, Hsu W-H, Chen S-J, Su M-H, Liu S-H, Cheng Y-C, Chen C-Y, et al., Ganoderma tsugae induces S phase arrest and apoptosis in doxorubicin-resistant lung adenocarcinoma H23/0.3 cells via modulation of the PI3K/Akt signaling pathway. Evid Based Complement Alternat Med. 2012; 2012:371286. doi:https://doi.org/10.1155/2012/371286
- Li Y-G, Ji D-F, Zhong S, Liu P-G, Lv Z-Q, Zhu J-X, Chen J-E, Chen H-P. Polysaccharide from Phellinus linteus induces S-phase arrest in HepG2 cells by decreasing calreticulin expression and activating the P27kip1-cyclin A/D1/E-CDK2 pathway. J Ethnopharmacol. 2013;150(1):187–95. doi:https://doi.org/10.1016/j.jep.2013.08.028
- Hu H, Ahn N-S, Yang X, Lee Y-S, Kang K-S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer. 2002;102(3):250–3. doi:https://doi.org/10.1002/ijc.10707
- Wang T, Xie Z-P, Huang Z-S, Li H, Wei A-Y, Di J-M, Xiao H-J, Zhang Z-G, Cai L-H, Tao X, et al. Total triterpenoids from Ganoderma lucidum suppresses prostate cancer cell growth by inducing growth arrest and apoptosis. J Huazhong Univ Sci Technol Med Sci. 2015;35(5):736–41. doi:https://doi.org/10.1007/s11596-015-1499-x
- Lee HS, Kim EJ, Kim SH. Ethanol extract of Innotus obliquus (Chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells. Nutr Res Pract. 2015;9(2):111–6. doi:https://doi.org/10.4162/nrp.2015.9.2.111
- Li X, Xie Y, Peng J, Hu H, Wu Q, Yang BB. Ganoderiol F purified from Ganoderma leucocontextum retards cell cycle progression by inhibiting CDK4/CDK6. Cell Cycle. 2019;18(21):3030–43. doi:https://doi.org/10.1080/15384101.2019.1667705
- Wang L, Zhong N, Liu S, Zhu X, Liu Y. High glucose stimulates proliferation and inhibits apoptosis of non-small-cell lung cancer cells by JNK-mediated downregulation of p53 pathway. Acta Biochim Biophys Sin (Shanghai)). 2017;49(3):286–8. doi:https://doi.org/10.1093/abbs/gmw137
- Li X, Li J, Cai Y, Peng S, Wang J, Xiao Z, Wang Y, Tao Y, Li J, Leng Q, et al. Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer. Cancer Lett. 2018;418:211–20. doi:https://doi.org/10.1016/j.canlet.2018.01.031
- Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. doi:https://doi.org/10.1080/01926230701320337
- Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther. 2005;4(2):139–63. doi:https://doi.org/10.4161/cbt.4.2.1508
- Fulda S. Evasion of apoptosis as a cellular stress response in cancer. Int J Cell Biol. 2010;2010:370835. doi:https://doi.org/10.1155/2010/370835
- Ji Z, Tang Q, Hao R, Zhang J, Pan Y. Induction of apoptosis in the SW620 colon carcinoma cell line by triterpene-enriched extracts from Ganoderma lucidum through activation of caspase-3. Oncol Lett. 2011;2(3):565–70. doi:https://doi.org/10.3892/ol.2011.275
- Ruan W, Popovich DG. Ganoderma lucidum triterpenoid extract induces apoptosis in human colon carcinoma cells (Caco-2). Biomed Prev Nutr. 2012;2(3):203–9. doi:https://doi.org/10.1016/j.bionut.2012.03.004
- )Elkhateeb WA, Zaghlol GM, El-Garawani IM, Ahmed EF, Rateb ME, Abdel Moneim AE. Abdel Moneim AE. Ganoderma applanatum secondary metabolites induced apoptosis through different pathways: In vivo and in vitro anticancer studies. Biomed Pharmacother. 2018;101:264–77. doi:https://doi.org/10.1016/j.biopha.2018.02.058
- Setiawati A. Cytotoxic of Ganoderma lucidum in colon cancer through cyclooxygenase 2 (COX-2) as its molecular target. JTLS. (2)2017;7:177–83. doi:https://doi.org/10.11594/jtls.07.02.14
- Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknaes M, Hektoen M, Lind GE, Lothe RA. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2:e71. doi:https://doi.org/10.1038/oncsis.2013.35
- Garufi A, D’Orazi G. High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity. J Exp Clin Cancer Res. 2014;33(1):79. doi:https://doi.org/10.1186/s13046-014-0079-4
- Baldari S, Garufi A, Granato M, Cuomo L, Pistritto G, Cirone M, D’Orazi G. Hyperglycemia triggers HIPK2 protein degradation. Oncotarget. 2017;8(1):1190–203. doi:https://doi.org/10.18632/oncotarget.13595
- Mhaidat NM, Bouklihacene M, Thorne RF. 5-Fluorouracil-induced apoptosis in colorectal cancer cells is caspase-9-dependent and mediated by activation of protein kinase C-δ. Oncol Lett. 2014;8(2):699–704. doi:https://doi.org/10.3892/ol.2014.2211